Contaminating, potentially alloreactive (IFN-γ−) T-cell quantities were less prominent in Prodigy products than in Plus [Prodigy 3.6–20.8 vs. Plus: 19.9–80.0% (14)], which may contribute to improved prevention of the GvHD in recipients. The gene discussed is IFNA1; the disease is graft versus host disease.